Catheters Global Market Report 2024

“Catheters Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on catheters market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for catheters? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The catheters market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product: Cardiovascular Catheters; Neurovascular Catheters; Urology Catheters; Intravenous Catheters; Specialty Catheters
• 2) By Lumen: Single-lumen; Double-lumen; Triple-lumen
• 3) By End User: Hospitals & Clinics; Ambulatory Surgical Centers
• Companies Mentioned: Boston Scientific Corporation; Coloplast A/S; ConvaTec Group Plc; Edwards Lifesciences Corporation; Hollister Incorporated
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

A catheter is a medical device employed for the extraction of urine or other fluids from the body. These devices serve various medical purposes, including the administration of fluids, medications, or gases, as well as the drainage of fluids or urine.

The primary types of catheters encompass cardiovascular, neurovascular, urology, intravenous, and specialty catheters. The cardiovascular catheter market pertains to the sales of catheters specifically designed for cardiac purposes. Catheters are available in three variations such as single-lumen, double-lumen, and triple-lumen. They find application in diverse healthcare settings, including hospitals, clinics, and ambulatory surgical centers.

The catheter market research report is one of a series of new reports from The Business Research Company that provides catheter market statistics, including global market size, regional shares, competitors with a catheter market share, detailed catheter market segments, market trends and opportunities, and any further data you may need to thrive in the catheter industry. This catheter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The catheters market size has grown strongly in recent years. It will grow from $29.97 billion in 2023 to $32.5 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The expansion observed in the historical period can be attributed to several factors, including the increasing aging population, the prevalence of chronic diseases, a shift toward minimally invasive surgical procedures, heightened awareness and treatment of urinary incontinence, and the overall expansion of healthcare infrastructure.

The catheters market size is expected to see strong growth in the next few years. It will grow to $46.81 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. Anticipated growth in the forecast period can be attributed to various factors, including the increased use of telemedicine and remote patient monitoring, a focus on personalized medicine, the utilization of regenerative medicine techniques, a growing shift towards patient-centric care, and an increasing emphasis on sustainable and eco-friendly catheter materials. Noteworthy trends expected in the forecast period encompass the integration of artificial intelligence (AI) and robotics in catheter-based procedures, the development of advanced infection control technologies, ongoing technological advancements, product innovations, and the adoption of the Internet of Things (IoT).

The catheters market is poised for growth due to the escalating prevalence of cardiovascular disorders. Cardiac catheterization, involving the insertion of a catheter through a blood vessel to the heart, has become integral for diagnosing and treating cardiovascular diseases. The surge in cardiovascular conditions and the increasing demand for related treatments are anticipated to drive the demand for catheters. As per the May 2023 report from the Center for Disease Control and Prevention, heart disease accounted for a significant percentage of all deaths in different ethnic groups in the US in 2021. With approximately 697,000 deaths attributed to heart disease that year, representing nearly 1 in 5 deaths, the rising prevalence of cardiovascular disorders is a substantial driver for the catheter market.

Additionally, the catheters market is expected to benefit from the increasing incidence of neurological conditions. Neurological problems affecting the brain, nerves, and spinal cord necessitate interventions using specialized catheters like neurovascular catheters. These catheters play a crucial role in both diagnosis and treatment during neurovascular procedures. According to a 2022 report from the World Health Organization, one in four people over the age of 25 is projected to experience a stroke during their lifetime. With 13.7 million individuals facing their first stroke each year, and 5.5 million succumbing to it, neurological conditions are a significant driver for the catheters market.

A prominent trend in the catheter market is the rise of strategic collaborations between companies. To enhance research and development efforts for innovative products and bolster market share, companies in the catheter market are engaging in strategic partnerships. An illustrative example is the collaboration between CEMMA, a China-based advanced medical equipment company, and LipoCoat, a Dutch biotech company specializing in catheter products. This collaboration, initiated in April 2022, focuses on co-creating a central venous catheter with LipoCoat's bioinspired coating technology, emphasizing long-term infection prevention. Strategic collaborations are proving to be instrumental in advancing catheter technologies and addressing evolving healthcare needs.

Companies in the catheter market are at the forefront of introducing cutting-edge technologies to cater to the diverse needs of patients and healthcare professionals. An exemplar of this innovation is Medtronic PLC, which, in July 2021, launched the Prevail drug-coated balloon (DCB) Catheter in Europe, subsequent to receiving the European Conformity (CE) mark. This coronary DCB is utilized in percutaneous coronary intervention (PCI) procedures, addressing blocked or narrowed coronary arteries in patients with coronary artery disease (CAD). The Prevail DCB, featuring PowerTrac technology, offers superior deliverability and enhanced control, particularly beneficial for challenging anatomies. Furthermore, Teleflex Incorporated, a US-based healthcare company, introduced two advanced systems in January 2021-the Arrow ErgoPack Complete multi-lumen access catheter (MAC) system and the Arrow ErgoPack Complete percutaneous sheath introducer (PSI) system. Highlighted by the Arrowg+ard Blue MAC and PSI catheters, these systems are designed to address a spectrum of patient needs, including those with trauma or cardiac conditions. The high-flow Arrow MAC catheters provide comprehensive antimicrobial protection against various infectious pathogens, crucial for preventing central line-associated bloodstream infections (CLABIs). Simultaneously, Arrow PSI catheters are tailored to offer both antimicrobial protection and optimal access for hemodynamic monitoring.

In a strategic move to enhance its capabilities, VitalPath, a US-based manufacturer of custom, highly complex catheter solutions, acquired Modern Catheter Technologies in January 2022. This acquisition aimed to broaden VitalPath's expertise, particularly in neurovascular and electrophysiology fields, including the use of microcatheters and applications in peripheral vascular domains. Modern Catheter Technologies, a US-based manufacturer of catheters, contributed valuable knowledge to further enrich VitalPath's offerings and serve the evolving needs of the medical community.

Major companies operating in the catheters market include Boston Scientific Corporation, Coloplast A/S, ConvaTec Group PLC, Edwards Lifesciences Corporation, Hollister Incorporated, Johnson & Johnson, Medtronic PLC, B. Braun Melsungen AG, Terumo Corporation, Lumend Corporation, Covidien Ag, Acist Medical Systems Inc., Cook Medical Inc., Becton Dickinson and Company, Stryker Corporation, Merit Medical Systems Inc., Abbott Laboratories, Manfred Sauer GmbH, Koninklijke Philips N.V., Teleflex Incorporated, C. R. Bard Inc., Vascular Solutions Inc., Cordis Corporation, Rochester Medical Corporation, Navilyst Medical Inc., AngioDynamics Inc., Cardinal Health Inc., Fujifilm Holdings Corporation, Olympus Corporation, Penumbra Inc., Philips Healthcare, Siemens Healthineers AG, Smiths Medical Inc.

North America was the largest region in the catheters market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the catheters market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The catheter market consists of sales of Indwelling catheter, Condom catheter, Intermittent self-catheter. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.